IXHL · Incannex Healthcare Inc
United States · RS rating 13 · As of 2026-10-14
| Price | 2.86 USD |
|---|---|
| 1-day change | -1.7% |
| RS rating (overall / 1M / 3M / 12M) | 13 / 14 / 33 / 7 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 19 / 4 / 21 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +0.0% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +80.1% |
| Market cap (USD) | $53.0M |